|
PTPN23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.981610E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.088400E-01 |
| Normal-vs-Stage2 |
4.466400E-01 |
| Normal-vs-Stage3 |
7.395800E-02 |
| Normal-vs-Stage4 |
9.122200E-01 |
| Stage1-vs-Stage2 |
8.121000E-01 |
| Stage1-vs-Stage3 |
4.247600E-01 |
| Stage1-vs-Stage4 |
1.661240E-01 |
| Stage2-vs-Stage3 |
4.274000E-01 |
| Stage2-vs-Stage4 |
3.687800E-01 |
| Stage3-vs-Stage4 |
4.989700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.643630E-01 |
| Normal-vs-AfricanAmerican |
1.730420E-01 |
| Normal-vs-Asian |
9.895800E-01 |
| Caucasian-vs-AfricanAmerican |
8.680700E-03 |
| Caucasian-vs-Asian |
1.748790E-01 |
| AfricanAmerican-vs-Asian |
1.462550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.239800E-01 |
| Normal-vs-Female |
1.864250E-01 |
| Male-vs-Female |
7.932400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.900620E-01 |
| Normal-vs-Age(41-60Yrs) |
3.434000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.479200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.457100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.171000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.617400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.148300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.153800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.777400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.263510E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.911800E-02 |
| Classical-VS-Follicular |
2.812200E-02 |
| Classical-VS-Other |
2.217000E-01 |
| Classical-VS-Normal |
5.749000E-01 |
| Tall-VS-Follicular |
9.481600E-01 |
| Tall-VS-Other |
7.467000E-01 |
| Tall-VS-Normal |
7.521600E-02 |
| Follicular-VS-Other |
7.716600E-01 |
| Follicular-VS-Normal |
5.442100E-02 |
| Other-VS-Normal |
2.123200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.666400E-01 |
| Normal-vs-N1 |
1.099990E-01 |
| N0-vs-N1 |
3.598800E-01 |
|
|
